Report
Peter Farren

Colombie : relais de croissance coûteux et différé - VENTE - OC 14,8€ (vs 13,7€)

Les publications intérimaires de JM concentrent désormais l’attention, non pas sur ce qui va mieux que bien, la Pologne de Biedronka qui a soutenu une croissance LFL de +9,5% au T2 (+19,4% en cumul sur 2 ans), et le Portugal de Recheio et Pingo Doce qui amorce un nouveau cycle de croissance, mais sur les pertes du BM colombien (Ara) et accessoirement d’Hebe, dont le statut de start-up soulève des interrogations croissantes. Il est logique que le groupe surinvestisse dans ces relais de croissance, alors que ses activités core lui donnent une marge de manoeuvre élargie en matière de financement, mais cela n’aide pas naturellement à valider des retours sur investissements encore très hypothétiques à ce stade, tout autant que leur imputation dans le temps. Sévère semble le maintien de notre Opinion à la VENTE, mais notre évaluation (OC 14,8€ via DCF) ne supporte pas le moindre différé ou rupture de croissance.
Underlying
Jeronimo Martins SGPS S.A.

Jeronimo Martins S.G.P.S. is a holding company. Through its subsidiaries, Co. is engaged as a food distribution company with operations in Poland and Portugal. Co. operates in four segments: Portugal Retail, which comprises the business unit of JMR - Gestao de Empresas de Retalho, SGPS, S.A. (Pingo Doce supermarkets); Portugal Cash & Carry, which includes the wholesale business unit Recheio; Poland Retail, which includes the business unit with the brand Biedronka; and Others, which includes marketing services and representations, restaurants in Portugal, health and beauty retail in Poland, and its retail business in Colombia.

Provider
Invest Securities
Invest Securities

Since 2006, Invest Securities has become one of the leading players in investment services for funds and managers, to whom we offer a global and personalised service. Our track record differentiates us and proves our leadership in numerous promising sectors like property and growth companies.

Consisting of 13 different profiles (pharmacist, engineer, financier, etc), the DNA of our financial analysis office is value added and sector expertise. Through daily monitoring and detailed analyses of companies and sectors, we seek to provide a differentiating vision of our 120 stocks followed. Our ideas are circulated every day to nearly 1,000 professionals.

Analysts
Peter Farren

ResearchPool Subscriptions

Get the most out of your insights

Get in touch